Bausch + Lomb Debuts Nutritional Dry Eye Relief
Company Announcements

Bausch + Lomb Debuts Nutritional Dry Eye Relief

Bausch + Lomb Corporation (BLCO) has released an update.

Bausch + Lomb Corporation has introduced Blink NutriTears, a new dietary supplement for dry eye relief in the U.S., promising to address root causes and improve symptoms within weeks. This nutritional approach to eye health is expected to complement the existing dry eye treatments and cater to the growing number of younger adults affected by dry eye due to digital screen use and other modern stressors. Available soon both in stores and online, Blink NutriTears combines ingredients like lutein and vitamin D for a clinically supported improvement in tear film stability.

For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBausch Health price target lowered to $7 from $8 at Truist
TheFlyBausch + Lomb price target raised to $20 from $18 at RBC Capital
TheFlyBausch + Lomb initiated with an Outperform at Raymond James
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!